Biller Jonathan

Track

Insider profile

Biller Jonathan's trades of Vertex Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
321.66
Quantity 61,327
Value US$1,609,421
Transaction date
Proposed sale
Price
210.96
Quantity 23,692
Value US$2,134,759
Transaction date
Proposed sale
Price
473.68
Quantity 1,244
Value US$589,258
Transaction date
Proposed sale
Price
489.46
Quantity 2,476
Value US$1,211,903
Transaction date
Proposed sale
Price
499.00
Quantity 988
Value US$493,012
Transaction date
Proposed sale
Price
460.43
Quantity 1,925
Value US$886,328
Transaction date
Proposed sale
Price
449.00
Quantity 347
Value US$155,803
Transaction date
Proposed sale
Price
404.21
Quantity 694
Value US$280,522
Transaction date
Proposed sale
Price
455.06
Quantity 1,657
Value US$754,034
Transaction date
Proposed sale
Price
459.87
Quantity 3,433
Value US$1,578,744
Transaction date
Proposed sale
Price
461.66
Quantity 999
Value US$461,198
Transaction date
Proposed sale
Price
418.77
Quantity 1,738
Value US$727,821
Transaction date
Proposed sale
Price
346.76
Quantity 610
Value US$211,524
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-06
PrS Proposed sale
61,327
321.66
US$1,609,421 		61,327 321.66 US$1,609,421
2026-02-26 2026-02-25
PlS Planned sale
64,254 -21.5%
214.72
US$4,113,333 		64,254 -21.5% 214.72 US$4,113,333
2026-02-25 2026-02-25
PrS Proposed sale
23,692
210.96
US$2,134,759 		23,692 210.96 US$2,134,759
2026-02-19 2026-02-18
PlS Planned sale
1,244 -7.3%
473.68
US$589,258 		1,244 -7.3% 473.68 US$589,258
2026-02-18 2026-02-18
PrS Proposed sale
1,244
473.68
US$589,258 		1,244 473.68 US$589,258
2026-02-19 2026-02-17
PlS Planned sale
2,476 -12.7%
489.46
US$1,211,903 		2,476 -12.7% 489.46 US$1,211,903
2026-02-17 2026-02-17
PrS Proposed sale
2,476
489.46
US$1,211,903 		2,476 489.46 US$1,211,903
2026-02-18 2026-02-13
PlS Planned sale
988 -5.5%
499.00
US$493,012 		988 -5.5% 499.00 US$493,012
2026-02-13 2026-02-13
PrS Proposed sale
988
499.00
US$493,012 		988 499.00 US$493,012
2026-02-12 2026-02-11
PlS Planned sale
1,925 -8.5%
460.43
US$886,328 		1,925 -8.5% 460.43 US$886,328
2026-02-11 2026-02-11
PrS Proposed sale
1,925
460.43
US$886,328 		1,925 460.43 US$886,328
2025-12-05 2025-12-03
PlS Planned sale
347 -2.2%
449.00
US$155,803 		347 -2.2% 449.00 US$155,803
2025-12-03 2025-12-03
PrS Proposed sale
347
449.00
US$155,803 		347 449.00 US$155,803
2025-10-03 2025-10-02
PlS Planned sale
694 -4.2%
404.21
US$280,522 		694 -4.2% 404.21 US$280,522
2025-10-02 2025-10-02
PrS Proposed sale
694
404.21
US$280,522 		694 404.21 US$280,522
2025-02-19 2025-02-18
PlS Planned sale
1,657 -8.6%
455.06
US$754,034 		1,657 -8.6% 455.06 US$754,034
2025-02-18 2025-02-18
PrS Proposed sale
1,657
455.06
US$754,034 		1,657 455.06 US$754,034
2025-02-12 2025-02-11
PlS Planned sale
3,433 -17.4%
459.87
US$1,578,734 		3,433 -17.4% 459.87 US$1,578,734
2025-02-11 2025-02-11
PrS Proposed sale
3,433
459.87
US$1,578,744 		3,433 459.87 US$1,578,744
2024-10-03 2024-10-02
PlS Planned sale
999 -5.7%
461.66
US$461,198 		999 -5.7% 461.66 US$461,198
2024-10-02 2024-10-02
PrS Proposed sale
999
461.66
US$461,198 		999 461.66 US$461,198
2024-02-13 2024-02-12
PlS Planned sale
1,738 -8.7%
418.77
US$727,822 		1,738 -8.7% 418.77 US$727,822
2024-02-12 2024-02-12
PrS Proposed sale
1,738
418.77
US$727,821 		1,738 418.77 US$727,821
2023-10-03 2023-10-02
PlS Planned sale
610 -5.5%
346.76
US$211,524 		610 -5.5% 346.76 US$211,524
2023-10-02 2023-10-02
PrS Proposed sale
610
346.76
US$211,524 		610 346.76 US$211,524